Related Experiment Videos
Urinary protein excretion patterns in reactive (secondary) systemic amyloidosis
Rheumatology International
|January 1, 1988
Summary
Patients with amyloid nephropathy show an altered urinary excretion of immunoglobulin light chains, specifically a higher lambda/kappa ratio. This finding is independent of proteinuria levels and suggests a selective change in light chain excretion during kidney amyloid deposition.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Amyloid nephropathy, particularly secondary type AA, is linked to rheumatic diseases.
- Understanding the urinary markers of kidney damage is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the urinary excretion patterns of immunoglobulin light chains (kappa and lambda), immunoglobulin G, transferrin, and beta-2-microglobulin.
- To differentiate nonimmunoglobulin-related amyloid nephropathy from other glomerulopathies and rheumatic disease without nephropathy.
Main Methods:
- Comparative analysis of urinary biomarkers in four groups: amyloid nephropathy, nonamyloid glomerulopathy, rheumatic disease without nephropathy, and healthy controls.
- Quantification of immunoglobulin light chains kappa and lambda, immunoglobulin G, transferrin, and beta-2-microglobulin in urine and serum.
Main Results:
- Patients with amyloidosis exhibited a significantly higher urinary lambda/kappa light chain ratio compared to those with diabetic nephropathy or chronic glomerulonephritis.
- This elevated lambda/kappa ratio was observed across all proteinuria grades, from mild to heavy.
- Serum lambda/kappa light chain ratios did not differ between amyloidosis patients and healthy controls.
Conclusions:
- The study suggests a selective alteration in immunoglobulin light chain excretion in the urine of patients with amyloid deposition in the kidneys.
- The urinary lambda/kappa ratio may serve as a potential biomarker for distinguishing amyloid nephropathy.